Immunis Biomedical

Immunis Biomedical is a clinical-stage private biotechnology company developing novel secretome-based biologics for age-related immune dysfunction and disease. The company has developed a proprietary method to isolate clinical-grade, multi-active stem cell-derived products targeting age-driven diseases and has been recognized as a leader in its field.